cAMPfield Therapeutics

cAMPfield Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in San Diego, California. The company focuses on developing well-tolerated and highly effective oral medicines for immune-mediated inflammatory diseases, specifically inflammatory bowel disease (IBD). Its primary asset is prifemilast, a once-daily oral PDE4B-se... lective inhibitor designed to improve tolerability and efficacy over previous PDE4 inhibitors. The company serves patients with moderate-to-severe ulcerative colitis and Crohn's disease, delivering its value through the development of selective inhibitors that minimize central nervous system penetration and control cAMP levels.Read More